Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Building collapse in Brooklyn kills at least 2, injures more than 10
Israeli strike on southern Gaza hospital kills 5, Gaza civil defence says
Saudi Arabia says debris from intercepted Houthi missiles falls in Mecca region
Climate crisis is 'outrunning us', UN chief warns COP31
